The evaluation of Endoscopic Ultrasound-Guided Fine-needle Aspiration Using newly designed 22G Aspiration Needle with side port. -The Prospective Randomized, Controlled Trial of EUS-FNA Using 22G FNA needle with or without side port for Solid Pancreatic mass-

The evaluation of Endoscopic Ultrasound-Guided Fine-needle Aspiration Using newly designed 22G Aspiration Needle with side port. -The Prospective Randomized, Controlled Trial of EUS-FNA Using 22G FNA needle with or without side port for Solid Pancreatic mass- - The Prospective Randomized, Controlled Trial of EUS-FNA Using 22G Aspiration needle with or without side port for Solid Pancreatic mass.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008120

Enrollment

160

Registered

2012-07-01

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid pancreatic mass

Interventions

With side port group EUS-FNA using EZ shot 2 with side port (NA-230H-8022) Without side port group EUS-FNA using EZ shot 2 without side port (NA-220H-8022)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who have pancreatic mass which is detected by EUS. 2) age>20 3) Patients who understand and are willing to give a written informed consent about participation

Exclusion criteria

Exclusion criteria: 1) Patients with performance status 4. 2) Patients with ASA scores greater than or equal to 3. 3) Patients who receive anticoagulant agent. 4) Women suspected of being pregnant 5) Histologically confirmed by other methods. 6) Platelets is lower than 50,000/mm3. 7) INR PT (Prothrombin time) is higher than 1.5. 8) Patients who are judged inappropriate by chief (responsive) medical examiner.

Design outcomes

Primary

Measure	Time frame
accuracy rate	—

Secondary

Measure	Time frame
complication rate number of puncture Quality of the specimen	—

Countries

Japan

Contacts

Public ContactMichihiro no

Sapporo Medical University The 4th department of internal medicine

ishihiro@sapmed.ac.jp011-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026